HELEN SHIH: Open Payments
NPI 1750512240 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$31,613 in 63 payments from 10 companies in 2025. Trend: 2023 $23,158 · 2024 $17,020 · 2025 $31,613
Speaker / faculty: $22,301Travel & lodging: $5,816Food & beverage: $2,096Consulting: $1,400
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 29 | $21,826 |
| AstraZeneca Pharmaceuticals LP | 19 | $9,352 |
| Merck Sharp & Dohme LLC | 6 | $180 |
| Daiichi Sankyo Inc. | 2 | $58 |
| Rigel Pharmaceuticals, Inc. | 2 | $49 |
| Agios Pharmaceuticals, Inc. | 1 | $35 |
| Lilly USA, LLC | 1 | $34 |
| Kite Pharma, Inc. | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Celgene Corporation | 1 | $18 |
Products named: OPDIVO, KEYTRUDA, CALQUENCE, Vanflyta, TAVALISSE, PYRUKYND, Yescarta, VONVENDI.
Industry payments across CA — which companies pay providers there.
